期刊文献+

New insights into the immunology and evolution of HIV 被引量:5

New insights into the immunology and evolution of HIV
暂未订购
导出
摘要 Fewer than one million HIV infected individuals are currently receiving anti-retroviral therapy. Thelimitations of such treatment have underscored the need to develop more effective strategies to control thespread and pathogenesis of HIV. Typically, naturally occurring protective immune responses provide theparadigm for such development. It is now clear however that HIV can utilise the millieu of an activatedimmune system to its own replicative advantage. Mobilisation of the immune response, intended to thwartof HIV contributes to lack of immune control and the development of progressive disease in the majority ofinfected, untreated individuals. Further delineation of the intimate interactions between the HIV and theimmune system will be critical and recent advances in this direction are discussed. Fewer than one million HIV infected individuals are currently receiving anti-retroviral therapy. The limitations of such treatment have underscored the need to develop more effective strategies to control the spread and pathogenesis of HIV. Typically, naturally occurring protective immune responses provide the paradigm for such development. It is now clear however that HIV can utilise the millieu of an activated immune system to its own replicative advantage. Mobilisation of the immune response, intended to thwart the virus, may instead fuel its dissemination, 'immune escape' and spread. The immense genetic variation of HIV contributes to lack of immune control and the development of progressive disease in the majority of infected, untreated individuals. Further delineation of the intimate interactions between the HIV and the immune system will be critical and recent advances in this direction are discussed.
机构地区 Department
出处 《Cell Research》 SCIE CAS CSCD 2003年第1期1-7,共7页 细胞研究(英文版)
关键词 HIV immune response CTL EVOLUTION vaccine. HIV immune response CTL evolution vaccine.
  • 相关文献

参考文献35

  • 1[1]Mathers CD, Sadana R, Salomon JA, Murray C J, Lopez AD. Healthy life expectancy in 191 countries, 1999.Lancet 2001; 357(9269):685-91.
  • 2[2]Clark S. Experts predict global devastation due to HIV/AIDS. Lancet 2002; 360(9327):45.
  • 3[3]Stover J, Walker N, Garnett GP, et al. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 2002; 360(9326):73-7.
  • 4[4]Buve A, Bishikwabo-Nsarhaza K, Mutangadura G. The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 2002; 359(9322):2011-7.
  • 5[5]Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002;417(6884):95-8.
  • 6[6]Palella F J, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-60.
  • 7[7]Stebbing J, Gazzard B. Resistance in HIV. Journal of HIV therapy 2002; 12(4):181-5.
  • 8[8]Gerrish P. The rhythm of microbial adaptation. Nature 2001; 413(6853):299-302.
  • 9[9]Stebbing J, Portsmouth S, Gazzard B. Virus-host interactions. Journal of the Royal College of Obstetricians and Gynaecologists 2002; 9(3):152-9.
  • 10[10]Walker BD, Korber BT. Immune control of HIV: the obstacles of HLA and viral diversity. Nat Immunol 2001;2(6):473-5.

同被引文献26

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部